Astria Therapeutics, Inc.
ATXSDelisted Jan 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001454789
Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Astria Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −3 vs. Q1 2022
- Shares held
- 5.73M
- −477.9K (−7.7%) vs. Q1 2022
- Total value
- $17.2M
- −$24.5M (−58.7%) vs. Q1 2022
- New holders
- 4
- 8 more added
- Sold out
- 7
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATXS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 141 | $738.2M |
| Q3 2025 | 115 | $409.0M |
| Q2 2025 | 106 | $309.9M |
| Q1 2025 | 116 | $311.4M |
| Q4 2024 | 111 | $523.4M |
| Q3 2024 | 103 | $622.1M |
| Q2 2024 | 100 | $505.8M |
| Q1 2024 | 102 | $810.6M |
| Q4 2023 | 80 | $282.6M |
| Q3 2023 | 68 | $171.4M |
| Q2 2023 | 76 | $205.5M |
| Q1 2023 | 66 | $311.6M |
| Q4 2022 | 61 | $326.1M |
| Q3 2022 | 43 | $88.8M |
| Q2 2022 | 30 | $17.2M |
| Q1 2022 | 33 | $41.7M |
| Q4 2021 | 33 | $32.8M |
| Q3 2021 | 36 | $65.2M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Astria Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 1,281,197 | $3.84M | 0.12% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 911,736 | $2.73M | 0.63% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 760,857 | $2.28M | 0.06% | −501,336−39.7% | Reduced |
| Ikarian Capital, LLC | 592,123 | $1.78M | 0.74% | +499,900+542.1% | Added |
| Vanguard Group Inc | 503,410 | $1.51M | 0.00% | −29,158−5.5% | Reduced |
| FMR LLC | 377,445 | $1.13M | 0.00% | +23,561+6.7% | Added |
| Cormorant Asset Management, LP | 300,000 | $900.0K | 0.07% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 274,719 | $824.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 219,962 | $659.0K | 0.00% | −23,827−9.8% | Reduced |
| Bridgeway Capital Management, LLC | 114,279 | $343.0K | 0.01% | +50,000+77.8% | Added |
| Geode Capital Management, LLC | 84,196 | $252.0K | 0.00% | +6,089+7.8% | Added |
| Boothbay Fund Management, LLC | 75,773 | $227.0K | 0.01% | +75,773 | New |
| BlackRock Inc. | 61,457 | $185.0K | 0.00% | +11,071+22.0% | Added |
| Artal Group S.A. | 33,333 | $100.0K | 0.01% | 00.0% | Unchanged |
| Botty Investors LLC | 25,747 | $77.0K | 0.03% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 25,000 | $75.0K | 0.02% | 00.0% | Unchanged |
| Oppenheimer & Co Inc | 23,616 | $71.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,909 | $60.0K | 0.00% | −190−0.9% | Reduced |
| Millennium Management LLC | 16,917 | $51.0K | 0.00% | +16,917 | New |
| Renaissance Technologies LLC | 13,700 | $41.0K | 0.00% | +13,700 | New |
| Group One Trading, L.P. | 11,431 | $34.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 2,501 | $8.00K | 0.00% | −507−16.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,073 | $6.00K | 0.00% | +1,666+409.3% | Added |
| Bank of America Corp | 565 | $2.00K | 0.00% | +550+3,666.7% | Added |
| Benjamin F. Edwards & Company, Inc. | 333 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 77 | $0 | 0.00% | −1,258−94.2% | Reduced |
| Wells Fargo & Company | 64 | $0 | 0.00% | +6+10.3% | Added |
| Key Financial Inc | 66 | $0 | 0.00% | 00.0% | Unchanged |
| SOA Wealth Advisors, LLC. | 7 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 25 | $0 | 0.00% | +25 | New |
| VR Adviser, LLC | 0 | $0 | 0.00% | −538,999−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −24,809−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,530−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −15,341−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −11,597−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −11,500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −145−100.0% | Sold out |